This inventor holds 2 USPTO granted patents. Top assignees: Celltech R&d Limited, Genzyme Corporation. Active years: 1996-2005.
Company Filing History:
Years Active: 1996-2005
Title: Nicholas David Tyrrell: Innovator in Pharmaceutical Chemistry
Introduction
Nicholas David Tyrrell is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and formulations. With a total of 2 patents, Tyrrell has established himself as a key figure in the industry.
Latest Patents
Tyrrell's latest patents include a process for the preparation of phenylalanine enamide derivatives. This patent describes a method for synthesizing a specific class of phenylalanine enamide derivatives. Additionally, he has developed a crystallization process for preparing glycerophosphocholine, which is essential in various biochemical applications.
Career Highlights
Throughout his career, Nicholas David Tyrrell has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Genzyme Corporation and Celltech R&D Limited. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Tyrrell has collaborated with several professionals in his field, including Michael Handforth Brookes and Christopher T. Evans. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical products.
Conclusion
In summary, Nicholas David Tyrrell is a distinguished inventor whose work has significantly impacted pharmaceutical chemistry. His patents and collaborations reflect his commitment to advancing the field and improving healthcare solutions.